Literature DB >> 22991008

Final hearings begin in epic legal battle over Novartis drug in India.

Ganapati Mudur.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22991008     DOI： 10.1136/bmj.e6257

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

1.  "To patent or not to patent? the case of Novartis' cancer drug Glivec in India".

Authors:  Ravinder Gabble; Jillian Clare Kohler
Journal:  Global Health       Date:  2014-01-06       Impact factor: 4.185
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.